In vitro efficacy of synthetic antimicrobial peptide SET-M33 against poultry isolates with diverse antimicrobial resistance phenotypes
Microbiology Spectrum · 11.11.2026
DOI: 10.1128/spectrum.01859-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, online erschienen am 11.11.2026. Verfasst von Ana Laura Pereira Lourenço und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unitat Mixta d'Investigació IRTA UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (…. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE Framework Programme, Ministerio de Ciencia e Innovación, Ministero dell'Istruzione, dell'Università e della Ricerca.
Abstract (Originalsprache)
Antimicrobial resistance is an impactful One Health issue. One of its drivers is the extensive use of antibiotics in both human and animal production systems, and despite regulatory restrictions on antibiotic use in poultry farming, antimicrobial resistance remains a major challenge. Consequently, animals are at higher risk of harder-to-treat diseases and play a role as resistance reservoirs, highlighting the need for alternative antimicrobial strategies. Toward this end, antimicrobial peptides (AMPs) have emerged as promising candidates due to their broad-spectrum activity and lower propensity to induce resistance. However, the effectiveness of AMPs against poultry pathogens, and in particular multidrug-resistant strains, is largely unclear. Here, we evaluated SET-M33, a synthetic tetrabranched AMP, against four species of clinically relevant pathogens in poultry, namely, Escherichia coli , Salmonella enterica , Enterococcus faecalis , and Enterococcus cecorum . Using a panel of 141 field isolates, we found that SET-M33 broadly inhibited bacterial growth at low micromolar concentrations (median minimum inhibitory concentrations of 2.5 and 5 μM for gram-negative and gram-positive strains, respectively), including in multidrug-resistant isolates. To examine the potential impact of SET-M33 on host cells, we established an in vitro co-cultivation system using chicken intestinal organoids. We found that SET-M33 retains its antimicrobial activity in organoid-microbe co-cultures at concentrations that preserve host cell viability. These findings demonstrate the potential of SET-M33 as a new antimicrobial agent against pathogens in poultry. IMPORTANCE Antimicrobial resistance is an important One Health issue that affects human and animal health. In particular, antimicrobial resistance remains a challenge in poultry farming, where animals are at a higher risk of harder-to-treat diseases and play a role as resistance reservoirs. To solve this issue, we need alternative antimicrobial strategies, and antimicrobial peptides have emerged as particularly promising candidates. Here, we examined the efficacy of one such new antimicrobial, the synthetic antimicrobial peptide SET-M33, against a large panel of poultry pathogen isolates. We found that SET-M33 was highly effective against the vast majority of isolates, including strains that are multidrug resistant or resistant to other antimicrobial peptides. To examine the potential impact of SET-M33 on the host, we established an in vitro co-cultivation system using chicken intestinal organoids. We found that SET-M33 retains its antimicrobial activity in organoid-microbe co-cultures at concentrations that preserve host cell viability.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unitat Mixta d'Investigació IRTA UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia, Spain.
- IRTA, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la UAB, Bellaterra, Catalonia, Spain.
- Department of Material Science and Engineering, Universitat Politècnica de Catalunya, Barcelona, Spain.
- Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Bellaterra, Catalonia, Spain.
- Centre de Sanitat Avícola de Catalunya i Aragó (CESAC), Reus, Catalonia, Spain.
- Department of Medical Biotechnology, University of Siena, Siena, Italy.
ORCID-Profile: Ana Laura Pereira Lourenço, Alessia Maranesi, Gerardo Ceada, Teresa Ayats, Nuria Aloy, Noelia Antilles, Chiara Falciani, Alessandro Pini, Karl Kochanowski, Marta Cerdà-Cuéllar
Förderung
- HORIZON EUROPE Framework Programme
- Ministerio de Ciencia e Innovación
- Ministero dell'Istruzione, dell'Università e della Ricerca
- CERCA program
Zitieren
APA
Pereira Lourenço, A. L., Maranesi, A., Ceada, G., Ayats, T., Aloy, N., Navarro, N., Antilles, N., Biarnés, M., Falciani, C., Pini, A., Kochanowski, K., & Cerdà-Cuéllar, M. (2026). In vitro efficacy of synthetic antimicrobial peptide SET-M33 against poultry isolates with diverse antimicrobial resistance phenotypes. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01859-26
Vancouver
Pereira Lourenço AL, Maranesi A, Ceada G, Ayats T, Aloy N, Navarro N, et al. In vitro efficacy of synthetic antimicrobial peptide SET-M33 against poultry isolates with diverse antimicrobial resistance phenotypes. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01859-26
BibTeX
@article{PereiraLoureno2026,
author = {Pereira Lourenço, Ana Laura and Maranesi, Alessia and Ceada, Gerardo and Ayats, Teresa and Aloy, Nuria and Navarro, Nuria and Antilles, Noelia and Biarnés, Mar and Falciani, Chiara and Pini, Alessandro and Kochanowski, Karl and Cerdà-Cuéllar, Marta},
title = {In vitro efficacy of synthetic antimicrobial peptide SET-M33 against poultry isolates with diverse antimicrobial resistance phenotypes},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.01859-26}
}
EUVIMED